Specialty Microbiology

Microbiology Eurofins Medinet Anti-Infective Services offers the full spectrum of laboratory-based tests required by the US FDA to characterize new drugs as part of the New Drug Application (NDA).  Such testing includes:

  • Molecular Characterization (PCR, Sequencing)
  • Molecular Typing (PFGE, Ribotyping)
  • Lead Compound Screening
  • Resistance Development
  • Bactericidal Activities (Timekill)
  • Synergy/Antagonism
  • Post-Antibiotic Effect (PAE)
  • Development of Disk Diffusion and MIC Methodologies
  • Quality Control Range Development
  • Interpretive Breakpoint Determinations


Based on your specific requirements, our expert staff will work with you to develop an appropriate program to meet your anti-infective drug development needs.